| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| GOTCHER PETER C | Director | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO | /s/ Daniel Rodriguez as Attorney-in-Fact for Peter Gotcher | 05 Feb 2026 | 0000935901 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DLB | Class A Common Stock | Award | $0 | +3,908 | +9.6% | $0.000000 | 44,641 | 03 Feb 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. |
| F2 | Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |